ResearcherRoswell Park Comprehensive Cancer CenterActive in the last 2 years
Zachary E. Stiles
Matched on ORCID iD 0000-0002-6393-5079; OpenAlex author ID A5073229562. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 5
- Chemotherapy switch for nonresponse or progression on neoadjuvant chemotherapy for pancreatic adenocarcinoma. Co-author DOI 10.1002/jso.27803↗
- Nationwide analysis of unplanned conversion during minimally invasive distal pancreatectomy for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.hpb.2023.08.009↗
- The utilization and impact of adjuvant therapy following neoadjuvant therapy and resection of pancreatic adenocarcinoma: does more really matter? First author DOI 10.1016/j.hpb.2020.02.011↗
- Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2019.04.005↗
- Clinical significance of MUC13 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2017.12.003↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stephen W. Behrman · 4 shared papers, 2018–2023 · strength 0.49
- Paper Nationwide analysis of unplanned conversion during minimally invasive distal pancreatectomy for pancreatic adenocarcino… DOI 10.1016/j.hpb.2023.08.009↗
- Paper The utilization and impact of adjuvant therapy following neoadjuvant therapy and resection of pancreatic adenocarcinoma… DOI 10.1016/j.hpb.2020.02.011↗
- Paper Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. DOI 10.1016/j.biomaterials.2019.04.005↗
- Paxton Vandiver Dickson · 2 shared papers, 2020–2023 · strength 0.34
- Paper Nationwide analysis of unplanned conversion during minimally invasive distal pancreatectomy for pancreatic adenocarcino… DOI 10.1016/j.hpb.2023.08.009↗
- Paper The utilization and impact of adjuvant therapy following neoadjuvant therapy and resection of pancreatic adenocarcinoma… DOI 10.1016/j.hpb.2020.02.011↗
- Leonid Cherkassky · 1 shared paper, 2024 · strength 0.23
- Brendan L. Hagerty · 1 shared paper, 2024 · strength 0.23
- Christos K Fountzilas · 1 shared paper, 2024 · strength 0.23
- Meena Jaggi · 2 shared papers, 2018–2019 · strength 0.15
- Murali Mohan Yallapu · 2 shared papers, 2018–2019 · strength 0.15
- Saini Setua · 2 shared papers, 2018–2019 · strength 0.15
- Subhash C. Chauhan · 2 shared papers, 2018–2019 · strength 0.15
- Sheema Khan · 2 shared papers, 2018–2019 · strength 0.15
- Justin A. Drake · 1 shared paper, 2020 · strength 0.12
- Evan Scott Glazer · 1 shared paper, 2020 · strength 0.12
- Bilal Bin Hafeez · 1 shared paper, 2019 · strength 0.08
- Andrew E. Massey · 1 shared paper, 2019 · strength 0.08
- Sonam Kumari · 1 shared paper, 2019 · strength 0.08
- Lei Wang · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.